New Issue: Credit Suisse prices $11.95 million Accelerated Return Notes on biotech stocks

By Devika Patel

Knoxville, Tenn., Feb. 28 – Credit Suisse AG, London Branch priced $11.95 million of 0% Accelerated Return Notes due April 27, 2018 linked to a basket of stocks, according to a 424B2 filing with the Securities and Exchange Commission.

The underlying companies are Amgen Inc., Biogen Inc. and Celgene Corp.

The payout at maturity will be par of $10 plus triple any basket gain, up to a maximum payout of 19.75%. Investors will lose 1% for each 1% basket decline.

BofA Merrill Lynch is the agent.

Issuer:	Credit Suisse AG, London Branch
Issue:	Accelerated Return Notes
Underlying basket:	Amgen Inc. (Nasdaq: AMGN), Biogen Inc. (Nasdaq: BIIB) and Celgene Corp. (Nasdaq: CELG), equally weighted
Amount:	$11,951,860
Maturity:	April 27, 2018
Coupon:	0%
Price:	Par of $10.00
Payout at maturity:	Par plus triple any index gain, capped at 19.75%; 1% loss for each 1% decline
Initial stock levels:	$174.01 for Amgen, $284.75 for Biogen, $119.46 for Celgene
Pricing date:	Feb. 23
Settlement date:	March 2
Agent:	BofA Merrill Lynch
Fees:	2%
Cusip:	22547V410

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.